Amsterdam UMC, University of Amsterdam, Center for Experimental and Molecular Medicine, Meibergdreef 9, Amsterdam, Netherlands.
Department of Internal Medicine, Yale University School of Medicine, 06511, New Haven, CT, USA.
Sci Rep. 2019 Feb 5;9(1):1431. doi: 10.1038/s41598-018-37922-8.
The causative agents of Lyme borreliosis, spirochetes belonging to the Borrelia burgdorferi sensu lato group, have developed several ways to protect themselves against killing by the host complement system. In addition, it has been shown that serum sensitive isolates are (partially) protected by the Ixodes Tick Salivary Lectin Pathway Inhibitor (TSLPI) protein; a salivary gland protein that inhibits the function of Mannose Binding Lectin (MBL). MBL is a C-type lectin that recognizes oligosaccharides on pathogens and activates the complement system via the lectin pathway. MBL deficiency has been linked to a more severe course of several infectious diseases and humans with detectable antibodies against B. burgdorferi are significantly more often MBL deficient compared to humans without antibodies against B. burgdorferi. Here we set out to investigate the role of MBL in the immune response against B. burgdorferi in more detail. We demonstrate that B. burgdorferi N40 needle-infected C57BL/6 MBL deficient mice harbored significantly higher B. burgdorferi numbers in skin tissue during the early course of infection. In line with these findings they also developed higher anti-B. burgdorferi IgG serum antibodies compared to WT controls. In contrast, B. burgdorferi loads in distant tissue such as heart, joints or bladder at later time points were similar for both mouse strains. These in vivo findings were corroborated using a B. burgdorferi N40-infected I. scapularis infestation model. We showed that MBL is capable of binding B. burgdorferi through its carbohydrate recognition domains, but in vitro complement killing assays, peritoneal macrophage and whole blood stimulations, phagocytosis assays and an in vivo migration experiment did not reveal the mechanism by which MBL facilitates early clearance of B. burgdorferi. To conclude, we show a protective role of MBL in the early stages of B. burgdorferi infection, yet the underlying mechanism warrants further investigation.
莱姆病的病原体是螺旋体,属于伯氏疏螺旋体属,它们已经发展出几种方法来保护自己免受宿主补体系统的杀伤。此外,已经表明血清敏感分离株部分受到节肢动物唾液莱姆病抑制素途径抑制剂(TSLPI)蛋白的保护;一种唾液腺蛋白,可抑制甘露糖结合凝集素(MBL)的功能。MBL 是一种 C 型凝集素,可识别病原体上的寡糖,并通过凝集素途径激活补体系统。MBL 缺乏与几种传染病的更严重病程有关,并且与没有针对 B. burgdorferi 抗体的人类相比,具有针对 B. burgdorferi 的可检测抗体的人类明显更常缺乏 MBL。在这里,我们着手更详细地研究 MBL 在针对 B. burgdorferi 的免疫反应中的作用。我们证明,在感染早期,N40 针状感染的 C57BL/6 MBL 缺陷型小鼠皮肤组织中的 B. burgdorferi 数量明显更高。与这些发现一致的是,与 WT 对照相比,它们还产生了更高的针对 B. burgdorferi 的 IgG 血清抗体。相比之下,在较晚的时间点,两种小鼠品系的心脏、关节或膀胱等远处组织中的 B. burgdorferi 负荷相似。在使用 B. burgdorferi N40 感染的 I. scapularis 侵染模型进行的体内研究中证实了这些发现。我们表明,MBL 通过其碳水化合物识别结构域能够结合 B. burgdorferi,但在体外补体杀伤测定、腹腔巨噬细胞和全血刺激、吞噬作用测定和体内迁移实验中,并未揭示 MBL 促进 B. burgdorferi 早期清除的机制。总之,我们证明了 MBL 在 B. burgdorferi 感染的早期阶段具有保护作用,但潜在的机制需要进一步研究。